These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2482515)

  • 21. Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence.
    Fuxe K; Agnati LF; Benfenati F; Andersson K; Camurri M; Zoli M
    Neurosci Lett; 1983 Dec; 43(2-3):185-90. PubMed ID: 6231493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of dopamine receptors in the rabbit renal artery: a histoautoradiographic study.
    Alessandrini C; Cavallotti C; De Rossi M; Fruschelli C; Gerli R; Mione MC; Sacchi G; Amenta F
    Pharmacology; 1984; 29(1):17-23. PubMed ID: 6205406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]spiperone binding to lymphocyte in extrapyramidal disease and in aging.
    Członkowska A; Jachowicz-Jeszka J; Członkowski A
    Brain Behav Immun; 1987 Sep; 1(3):197-203. PubMed ID: 2975511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ; Spuhler K; Prasad KN; Seeman P
    Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
    [No Abstract]   [Full Text] [Related]  

  • 28. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?
    Bondy B; Ackenheil M; Elbers R; Fröhler M
    Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
    Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands.
    Wazer DE; Rotrosen J
    J Pharm Pharmacol; 1984 Dec; 36(12):853-4. PubMed ID: 6151985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H] spiroperidol binding to brain neurotransmitter receptors.
    Withy RM; Mayer RJ; Strange PG
    FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes and their relation to dopamine receptors. A long-standing controversy.
    Vile JM; Strange PG
    Biochem Pharmacol; 1995 Mar; 49(6):747-53. PubMed ID: 7702632
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro binding characteristics of [3H]spiperone to the pituitary of the goldfish (Carassius auratus).
    Omeljaniuk RJ; Peter RE
    Gen Comp Endocrinol; 1989 Apr; 74(1):57-67. PubMed ID: 2737456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetic characteristics of neuroleptic binding sites on human lymphocytes].
    Izumrudova II; Zaĭtsev SV; Koshkin AA; Porodenko NV; Varfolomeev SD
    Bioorg Khim; 1990 Feb; 16(2):272-4. PubMed ID: 1971512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 May; 38(5):406-8. PubMed ID: 2423678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM; Krstich M; McDonald D; Gundlach AL
    Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.